Complication rates of transrectal and transperineal prostate fusion biopsies - is there a learning curve even in high volume interventional center?
- PMID: 37115178
- PMCID: PMC10335893
- DOI: 10.1590/S1677-5538.IBJU.2023.0054
Complication rates of transrectal and transperineal prostate fusion biopsies - is there a learning curve even in high volume interventional center?
Abstract
Purpose: To analyze the learning curve regarding complication rates of transrectal prostate biopsy (TRPB) versus transperineal prostate biopsy (TPPB), using real time software-based magnetic resonance imaging ultrasound (MRI-US) fusion techniques, along with first year experience of transperineal approach.
Materials and methods: retrospective unicentric cohort study at a quaternary care hospital. Medical records of all consecutive patients that underwent TPPB between March 2021 and February 2022, after the introduction of MRI-US fusion device, and those who underwent TRPB throughout the entire years of 2019 and 2020 were analyzed. All complications that occurred as consequences of the procedure were considered. Descriptive statistics, Chi-squared and Fisher tests were used to describe complications and compare the two groups.
Results: A total of 283 patients were included in the transperineal group and 513 in the transrectal group. The analysis of a learning curve for the transperineal method showed lower complications rates comparing the first six months of TPPB procedures (group 1); The complication rate for TPPB was lower than that of TRPB (55.1% versus 81.9%, respectively; p<0.01). TPPB showed specifically lower rates of hematuria (48.8% versus 66.3%;p<0.001) and rectal bleeding(3.5% versus 18.1%; p<0.001). There were no cases of prostatitis after transperineal biopsies and three cases (0.6%) after transrectal procedures.
Conclusions: We evidenced the learning curve for performing the transperineal biopsy, with a lower rate of complications for the experienced team, after 142 cases after 6 months of practice. The lower complication rate of TPPB and the absence of infectious prostatitis imply a safer procedure when compared to TRPB.
Keywords: Prostatic Neoplasms; Radiology, Interventional; complications [Subheading].
Copyright® by the International Brazilian Journal of Urology.
Conflict of interest statement
None declared.
Figures
Similar articles
-
A novel simplified transperineal prostate biopsy guided by perineal ultrasound.Br J Radiol. 2024 Jun 18;97(1159):1351-1356. doi: 10.1093/bjr/tqae097. Br J Radiol. 2024. PMID: 38781498 Free PMC article.
-
Transperineal prostate biopsy guided by which ultrasound transducer: transrectal or transperineal: a retrospective study.PeerJ. 2024 Nov 11;12:e18424. doi: 10.7717/peerj.18424. eCollection 2024. PeerJ. 2024. PMID: 39544422 Free PMC article.
-
Diagnostic Efficacy of Prostate Biopsy by Transperineal Colour Ultrasound Plus Magnetic Resonance Imaging for Prostate Cancer and Analysis of Oxidative Stress Injury in Patients.Arch Esp Urol. 2025 Apr;78(3):318-324. doi: 10.56434/j.arch.esp.urol.20257803.43. Arch Esp Urol. 2025. PMID: 40340997
-
Recent Advances and Current Role of Transperineal Prostate Biopsy.Urol Clin North Am. 2021 Feb;48(1):25-33. doi: 10.1016/j.ucl.2020.09.010. Urol Clin North Am. 2021. PMID: 33218591 Review.
-
A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches.Urol Oncol. 2020 Aug;38(8):650-660. doi: 10.1016/j.urolonc.2020.04.005. Epub 2020 Jun 3. Urol Oncol. 2020. PMID: 32505458
Cited by
-
Intraperitoneal Bleeding After Ultrasound-Guided Transperineal Prostate Biopsy.Case Rep Urol. 2024 Nov 6;2024:8819291. doi: 10.1155/2024/8819291. eCollection 2024. Case Rep Urol. 2024. PMID: 39544307 Free PMC article.
-
MRI-TRUS fusion targeted biopsy is highligheted in International Brazilian Journal of Urology.Int Braz J Urol. 2023 May-Jun;49(3):278-280. doi: 10.1590/S1677-5538.IBJU.2023.03.01. Int Braz J Urol. 2023. PMID: 37115174 Free PMC article. No abstract available.
-
Less qualitative multiparametric magnetic resonance imaging in prostate cancer can underestimate extraprostatic extension in higher grade tumors.Int Braz J Urol. 2024 Jan-Feb;50(1):37-45. doi: 10.1590/S1677-5538.IBJU.2023.0321. Int Braz J Urol. 2024. PMID: 38166221 Free PMC article.
-
Transperineal versus Transrectal MRI/TRUS fusion-guided prostate biopsy in a large, ethnically diverse, and multiracial cohort.Int Braz J Urol. 2024 Sep-Oct;50(5):616-628. doi: 10.1590/S1677-5538.IBJU.2024.0354. Int Braz J Urol. 2024. PMID: 39106117 Free PMC article.
-
Comparison of Morphological and Functional MRI Assessments of Periprostatic Fat for Predicting Prostate Cancer Aggressiveness.Int Braz J Urol. 2025 Jan-Feb;51(1):e20240318. doi: 10.1590/S1677-5538.IBJU.2024.0318. Int Braz J Urol. 2025. PMID: 39556849 Free PMC article.
References
-
- Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48. - PubMed
-
- World Health Organization . Guide de Cancer Early Diagnosis. Geneva: World Health Organization; 2017. No authors. Internet. https://apps.who.int/iris/bitstream/handle/10665/254500/9789241511940-en... .
-
- Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer. Clin Genitourin Cancer. 2017;15:e33–e36. - PubMed
-
- Derin O, Fonseca L, Sanchez-Salas R, Roberts MJ. Infectious complications of prostate biopsy: winning battles but not war. World J Urol. 2020;38:2743–2753. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical